Related Experiment Video
Updated: Jun 5, 2025
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Assessment of COVID-19 patients' outcome based on clinical profile, laboratory parameters, and clinical management: A
Shivani Khullar1, Varun Kothari1, Ruchi Kothari2
1Department of Microbiology, Dr. SN Medical College, Jodhpur, Rajasthan, India.
Insights
This study identified key mortality predictors in intensive care unit (ICU) patients with coronavirus disease 2019 (COVID-19). Comorbidities like hypertension and abnormal lab results significantly impacted outcomes, highlighting areas for improved critical care strategies.
Area of Science:
- Critical care medicine
- Infectious diseases
- Epidemiology
Background:
- The COVID-19 pandemic necessitated understanding factors influencing patient outcomes.
- Assessing clinical profiles, lab findings, and management is crucial for improving COVID-19 treatment and reducing mortality.
- This research aimed to identify mortality predictors in intensive care unit (ICU) patients with COVID-19.
Purpose of the Study:
- To assess mortality predictors in intensive care unit (ICU) patients diagnosed with COVID-19.
- To analyze the association between clinical characteristics, comorbidities, and patient outcomes.
- To identify factors contributing to higher mortality rates in severe COVID-19 cases.
Main Methods:
- Retrospective analysis of patient data from medical records.
- Inclusion of 202 ICU patients with COVID-19 confirmed by RT-PCR between March 2020 and July 2021.
- Statistical comparison of outcomes between discharged and deceased patients.
Main Results:
- Male predominance (72.8%) with a mean age of 58.42 years.
- Fever (92%), cough (48.5%), and dyspnea (35%) were common symptoms.
- Hypertension (38) and type 2 diabetes (36) were prevalent comorbidities; hypertension significantly associated with outcomes.
- Elevated body temperature, respiratory rate, low oxygen saturation, and mechanical ventilation use were significant factors.
Conclusions:
- Underlying comorbidities and complications like ARDS significantly increase mortality risk in COVID-19 patients.
- Abnormal laboratory parameters are associated with significant differences in ICU patient outcomes.
- Identifying these predictors can inform targeted interventions and improve critical care for COVID-19 patients.
Background:
The coronavirus disease 2019 (COVID-19) pandemic has presented an unprecedented challenge to the global healthcare system, prompting an urgent need to understand the factors influencing patient outcomes. Critical to improving treatment protocols and reducing mortality rates is an in-depth assessment of the clinical profile, laboratory findings, and management strategies employed in treating COVID-19 patients. This research provides valuable insights that could influence future therapeutic approaches and public health strategies, ultimately aiming to reduce the morbidity and mortality associated with COVID-19. The study aimed to assess mortality predictors in patients admitted to the intensive care unit (ICU) due to COVID-19.
Methods:
This study employed a retrospective approach, utilizing patient data from medical records. The collected data encompassed demographic and clinical profiles and details regarding the duration of admission and treatment. The evaluation focused on patients admitted to the ICU for COVID-19 between March 2020 and July 2021, with confirmation through real-time reverse transcriptase polymerase chain reaction (RT-PCR). Rigorous statistical analysis was conducted to compare outcomes between discharged and deceased patients.
Results:
The study included a total of 202 ICU patients admitted for COVID-19. Among the cases, 147 (72.8%) were males and 55 (27.2%) were females. The mean age was 58.42 years, with a standard deviation of 15.59 years. Fever (92%) emerged as the most frequently encountered symptom, followed by cough (48.5%) and dyspnea (35%). Patients with underlying comorbidities exhibited a higher susceptibility to developing a severe or critical disease. Hypertension (n = 38) was identified as the most prevalent comorbidity, followed by type 2 diabetes mellitus (n = 36). Hypertension has demonstrated a significant association with disease outcomes. Body temperature, respiratory rate, oxygen saturation, and mechanical ventilation played substantial roles in patient outcomes.
Conclusion:
The study revealed that underlying comorbidities and complications, such as acute respiratory distress syndrome (ARDS), were linked to significantly higher mortality rates among COVID-19 patients. Abnormal laboratory parameters also exhibited significant differences in the outcomes of ICU patients.
More Related Videos
10:38Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
Published on: January 16, 2019
08:05Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Related Concept Videos
01:16Clinical Trials
There are four phases in a clinical trial. A phase one...
01:11Observational Studies
There are three types of observational studies – Prospective, retrospective, and cross-sectional.
Prospective Study
Prospective studies, also known as longitudinal or cohort studies, are carried out by collecting future data from groups sharing similar characteristics. One...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
01:21Cancer Survival Analysis
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...